Monarda Fistulosa Flower Extract Decreases Interleukin-6 Production by Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophages

J Med Food. 2025 Oct;28(10):993-1002. doi: 10.1177/1096620X251362016. Epub 2025 Jul 24.

Abstract

Monarda fistulosa (M. fistulosa) is a flowering plant used as an herbal remedy due to its anti-inflammatory properties. In this study, we sought to test the anti-inflammatory properties of a M. fistulosa methanolic flower crude extract and found that the extract decreased lipopolysaccharide-induced interleukin-6 cytokine production by RAW 264.7 macrophages. We went on to characterize potential anti-inflammatory bioactive compounds present in the methanolic extract of M. fistulosa flower using liquid chromatography-tandem mass spectrometry and molecular networking analysis. In total, 183 compounds were putatively identified. These findings contribute to our knowledge of the anti-inflammatory medicinal properties and underlying chemistry of M. fistulosa.

Keywords: cytokines; herbal supplement; immunomodulation.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / pharmacology
  • Flowers / chemistry
  • Interleukin-6* / genetics
  • Interleukin-6* / immunology
  • Lipopolysaccharides / adverse effects
  • Macrophages* / drug effects
  • Macrophages* / immunology
  • Macrophages* / metabolism
  • Mice
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacology
  • RAW 264.7 Cells
  • Tandem Mass Spectrometry

Substances

  • Plant Extracts
  • Interleukin-6
  • Lipopolysaccharides
  • Anti-Inflammatory Agents